Drugs / Rozex
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02052999 Comparator | Feb → Jun 2013 | rosacea | Amorepacific Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rozex | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02052999 ↗ |
| Route | Topical | “Participants received topical Rozex gel 0.75% twice daily for 8 weeks” NCT02052999 ↗ |